CNC — Centene Corporation
NYSE
Q4 2025 Earnings Call Summary
February 6, 2026
Centene Corporation (CNC) Q4 2025 Earnings Call Summary
1. Key Financial Results and Metrics
- Q4 Adjusted Diluted Loss Per Share: $1.19
- Full Year Adjusted Diluted EPS: $2.08
- GAAP Diluted Loss Per Share: $2.24, impacted by a $389 million loss from divesting the remaining Magellan business.
- Total Premium and Service Revenue: $174.6 billion for the year.
- Health Benefits Ratio (HBR):
- Medicaid: 93% in Q4, showing a 190 basis points improvement from Q2.
- Marketplace: Slightly higher than expectations due to out-of-period items.
- Membership: Medicaid membership at 12.5 million, with a projected decline in 2026.
2. Strategic Updates and Business Highlights
- Medicaid: Focused on restoring profitability through improved execution and quality outcomes. Key initiatives include optimizing networks, implementing clinical programs, and enhancing fraud detection.
- Marketplace: Experienced a shift towards more bronze plan enrollments (30% of membership), with proactive pricing strategies in response to market changes.
- Medicare: Strong performance in Medicare Advantage and Part D, with a goal of breakeven in Medicare Advantage by 2027. Adjustments made to provider contracts to improve profitability.
3. Forward Guidance and Outlook
- 2026 Adjusted EPS Guidance: Expected to exceed $3, representing over 40% year-over-year growth.
- Revenue Projections: Anticipated premium and service revenue between $170 billion and $174 billion.
- Medicaid HBR: Expected to remain stable at around 93% for 2026.
- Marketplace Membership: Projected to decline to approximately 3.5 million by Q1 2026.
- Medicare Segment Growth: Expected to grow by approximately $7.5 billion, driven by increased membership and premium yield.
4. Challenges and Points of Concern
- Membership Attrition: Anticipated decline in Medicaid membership due to tighter eligibility criteria and program changes, with a projected 5-6% reduction in member months.
- Marketplace Pressures: The expiration of enhanced advanced premium tax credits (APTCs) may lead to increased market volatility and impact profitability.
- Medicare Rate Pressure: The 2027 advance notice suggests a more pressured view of rates, potentially affecting benefits and product selection for seniors.
- Competitive Dynamics: Ongoing margin pressures in Medicaid may lead to exits from the market by smaller plans, impacting overall competition and service quality.
5. Notable Q&A Insights
- Medicaid Rate Assumptions: Management expressed confidence in a conservative 4.5% rate increase for 2026, supported by two years of data on acuity and trends.
- Marketplace Dynamics: The shift towards bronze plans is seen as a market response, with early indications showing no alarming utilization patterns among these members.
- PBM Contract: The flexible and tailored contract with their PBM partner is expected to provide economic benefits and support margin targets across segments.
- Medicare Advantage Breakeven: No premium deficiency reserve (PDR) in 2026 suggests progress towards breakeven, although slight losses are still anticipated.
Overall, Centene is navigating a challenging landscape but is optimistic about restoring profitability and improving margins across its segments in 2026, while also addressing membership attrition and competitive pressures.
